{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:14:47Z","timestamp":1779390887365,"version":"3.53.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,5,16]],"date-time":"2009-05-16T00:00:00Z","timestamp":1242432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-244x-9-24","type":"journal-article","created":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T06:14:12Z","timestamp":1244528052000},"source":"Crossref","is-referenced-by-count":113,"title":["Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study"],"prefix":"10.1186","volume":"9","author":[{"given":"Rune A","family":"Kroken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torleif","family":"Ruud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Wentzel-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,5,16]]},"reference":[{"key":"572_CR1","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4088\/JCP.v68n1115","volume":"68","author":"TA Moore","year":"2007","unstructured":"Moore TA, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Robinson DG, Schooler NR, Shon SP, Stroup TS, Miller AL: The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry. 2007, 68: 1751-1762.","journal-title":"J Clin Psychiatry"},{"key":"572_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/oxfordjournals.schbul.a007071","volume":"30","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden LD, Tenhula WN, Boerescu D, Tek C, Sandson N, Steinwachs DM: The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003. Schizophr Bull. 2004, 30: 193-217.","journal-title":"Schizophr Bull"},{"key":"572_CR3","volume-title":"Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care","author":"National Institute for Clinical Excellence","year":"2002","unstructured":"National Institute for Clinical Excellence: Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. 2002, National Institute for Clinical Excellence. London"},{"key":"572_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.161.1.1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J: Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004, 161: 1-56. 10.1176\/appi.ajp.161.1.1.","journal-title":"Am J Psychiatry"},{"key":"572_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1192\/bjp.187.3.248","volume":"187","author":"W Gaebel","year":"2005","unstructured":"Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS: Schizophrenia practice guidelines: international survey and comparison. Br J Psychiatry. 2005, 187: 248-255. 10.1192\/bjp.187.3.248.","journal-title":"Br J Psychiatry"},{"key":"572_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.schres.2007.11.033","volume":"100","author":"R Tandon","year":"2008","unstructured":"Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ, Okasha A, Singh B, Stein DJ, Olie J-P, Fleischhacker WW, Moeller H-J: World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res. 2008, 100: 20-38. 10.1016\/j.schres.2007.11.033.","journal-title":"Schizophr Res"},{"key":"572_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1600-0447.2007.01030.x","volume":"115","author":"S Leucht","year":"2007","unstructured":"Leucht S: Psychiatric treatment guidelines: doctors' non-compliance or insufficient evidence?. Acta Psychiatr Scand. 2007, 115: 417-419. 10.1111\/j.1600-0447.2007.01030.x.","journal-title":"Acta Psychiatr Scand"},{"key":"572_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/08039480410005837","volume":"58","author":"E Johnsen","year":"2004","unstructured":"Johnsen E, Svingen GF, Jorgensen HA: Practice regarding antipsychotic therapy: a cross-sectional survey in two Norwegian hospitals. Nord J Psychiatry. 2004, 58: 313-317. 10.1080\/08039480410005837.","journal-title":"Nord J Psychiatry"},{"key":"572_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/01.yic.0000224785.68040.43","volume":"21","author":"C Barbui","year":"2006","unstructured":"Barbui C, Nose M, Mazzi MA, Thornicroft G, Schene A, Becker T, Bindman J, Leese M, Helm H, Koeter M, Weinmann S, Tansella M: Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. Int Clin Psychopharmacol. 2006, 21: 355-362. 10.1097\/01.yic.0000224785.68040.43.","journal-title":"Int Clin Psychopharmacol"},{"key":"572_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1055\/s-2003-41199","volume":"36","author":"I Bitter","year":"2003","unstructured":"Bitter I, Chou JC, Ungvari GS, Tang WK, Xiang Z, Iwanami A, Gaszner P: Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Pharmacopsychiatry. 2003, 36: 143-149. 10.1055\/s-2003-41199.","journal-title":"Pharmacopsychiatry"},{"key":"572_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","volume":"19","author":"M Lambert","year":"2004","unstructured":"Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D: Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry. 2004, 19: 415-422. 10.1016\/j.eurpsy.2004.06.031.","journal-title":"Eur Psychiatry"},{"key":"572_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1524-4733.2006.00083.x","volume":"9","author":"SL Tunis","year":"2006","unstructured":"Tunis SL, Faries DE, Nyhuis AW, Kinon BJ, Ascher-Svanum H, Aquila R: Cost-effectiveness of olanzapine as first-line treatment for schizophrenia: results from a randomized, open-label, 1-year trial. Value Health. 2006, 9: 77-89. 10.1111\/j.1524-4733.2006.00083.x.","journal-title":"Value Health"},{"key":"572_CR13","volume-title":"Acute Psychiatric Treatment in Norway \u2013 results from a multicenter study. (In Norwegian)","author":"T Ruud","year":"2006","unstructured":"Ruud T, Gr\u00e5we RW, Hatling T: Acute Psychiatric Treatment in Norway \u2013 results from a multicenter study. (In Norwegian). 2006, Sintef Helse, Trondheim, Norway"},{"key":"572_CR14","volume-title":"Global Assessment of Functioning \u2013 Split Version (S-GAF): Background and Scoring Manual","author":"S Karterud","year":"1998","unstructured":"Karterud S, Pedersen G, Loevdahl H, Friis S: Global Assessment of Functioning \u2013 Split Version (S-GAF): Background and Scoring Manual. 1998, Ullev\u00e5l University Hospital, Department of Psychiatry. Oslo, Norway"},{"key":"572_CR15","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Assosiation","year":"1994","unstructured":"American Psychiatric Assosiation: Diagnostic and Statistical Manual of Mental Disorders. 1994, American Psychiatric Publishing, Washington DC, 4","edition":"4"},{"key":"572_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1192\/bjp.172.1.11","volume":"172","author":"JK Wing","year":"1998","unstructured":"Wing JK, Beevor AS, Curtis RH, Park SB, Hadden S, Burns A: Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry. 1998, 172: 11-18. 10.1192\/bjp.172.1.11.","journal-title":"Br J Psychiatry"},{"key":"572_CR17","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders, Clinical Description and Diagnostic Guidelines","author":"World Health Organization","year":"1992","unstructured":"World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders, Clinical Description and Diagnostic Guidelines. 1992, World Health Organization, Geneva"},{"key":"572_CR18","volume-title":"Psychotropic Drug Directory","author":"S Bazire","year":"2005","unstructured":"Bazire S: Psychotropic Drug Directory. 2005, Fivepin Limited, Salisbury"},{"key":"572_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0022-3956(74)90071-5","volume":"11","author":"JM Davis","year":"1974","unstructured":"Davis JM: Dose equivalence of the antipsychotic drugs. J Psychiatr Res. 1974, 11: 65-69. 10.1016\/0022-3956(74)90071-5.","journal-title":"J Psychiatr Res"},{"key":"572_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4088\/JCP.v64n0607","volume":"64","author":"SW Woods","year":"2003","unstructured":"Woods SW: Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003, 64: 663-667.","journal-title":"J Clin Psychiatry"},{"key":"572_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0924-977X(97)00045-X","volume":"8","author":"JM Kane","year":"1998","unstructured":"Kane JM, Aguglia E, Altamura AC, Ayuso Gutierrez JL, Brunello N, Fleischhacker WW, Gaebel W, Gerlach J, Guelfi J-D, Kissling W, Lapierre YD, Lindstr\u00f8m E, Mendlewicz J, Racagni G, Carulla LS, Schooler NR: Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol. 1998, 8: 55-66. 10.1016\/S0924-977X(97)00045-X.","journal-title":"Eur Neuropsychopharmacol"},{"key":"572_CR22","volume-title":"ATC classification index with DDDs 2008. Oslo, Norway","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2008","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology: ATC classification index with DDDs 2008. Oslo, Norway. 2008"},{"key":"572_CR23","volume-title":"British National Formulary 2008","author":"Royal Pharmaceutical Society of Great Britain","year":"2008","unstructured":"Royal Pharmaceutical Society of Great Britain: British National Formulary 2008. 2008, RPS Publishing, London"},{"key":"572_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.4088\/JCP.v68n0808","volume":"68","author":"YM Bai","year":"2007","unstructured":"Bai YM, Ting CT, Chen JY, Chang WH, Wu B, Hung CH, Lin WK: Equivalent switching dose from oral risperidone to risperidone long-acting injection: a 48-week randomized, prospective, single-blind pharmacokinetic study. J Clin Psychiatry. 2007, 68: 1218-1225.","journal-title":"J Clin Psychiatry"},{"key":"572_CR25","volume-title":"Use of antipsychotics in patients aged 18\u201364 years with schizophrenia, mania or bipolar affective disorder. (In Danish)","author":"Danish National Board of Health","year":"2006","unstructured":"Danish National Board of Health: Use of antipsychotics in patients aged 18\u201364 years with schizophrenia, mania or bipolar affective disorder. (In Danish). 2006, Copenhagen, Denmark"},{"key":"572_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1744-859X-6-29","volume":"6","author":"A Ballerini","year":"2007","unstructured":"Ballerini A, Boccalon RM, Boncompagni G, Casacchia M, Margari F, Minervini L, Righi R, Russo F, Salteri A, Frediani S, Rossi A, Scatigna M: Clinical features and therapeutic management of patients admitted to Italian acute hospital psychiatric units: the PERSEO (psychiatric emergency study and epidemiology) survey. Ann Gen Psychiatry. 2007, 6: 29-10.1186\/1744-859X-6-29.","journal-title":"Ann Gen Psychiatry"},{"key":"572_CR27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/070674370104600404","volume":"46","author":"RM Procyshyn","year":"2001","unstructured":"Procyshyn RM, Kennedy NB, Tse G, Thompson B: Antipsychotic polypharmacy: a survey of discharge prescriptions from a tertiary care psychiatric institution. Can J Psychiatry. 2001, 46: 334-339.","journal-title":"Can J Psychiatry"},{"key":"572_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.schres.2005.01.015","volume":"77","author":"M Edlinger","year":"2005","unstructured":"Edlinger M, Hausmann A, Kemmler G, Kurz M, Kurzthaler I, Walch T, Walpoth M, Fleischhacker WW: Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period. Schizophr Res. 2005, 77: 25-34. 10.1016\/j.schres.2005.01.015.","journal-title":"Schizophr Res"},{"key":"572_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2006.02.023","volume":"84","author":"J Kreyenbuhl","year":"2006","unstructured":"Kreyenbuhl J, Valenstein M, McCarthy JF, Ganoczy D, Blow FC: Long-term combination antipsychotic treatment in VA patients with schizophrenia. Schizophr Res. 2006, 84: 90-99. 10.1016\/j.schres.2006.02.023.","journal-title":"Schizophr Res"},{"key":"572_CR30","first-page":"229","volume":"5","author":"PJ Weiden","year":"1999","unstructured":"Weiden PJ, Casey DE: \"Polypharmacy:\" Combining Antipsychotic Medications in the Treatment of Schizophrenia. Jrnl Prac Psych and Behav Hlth. 1999, 5: 229-233.","journal-title":"Jrnl Prac Psych and Behav Hlth"},{"key":"572_CR31","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"12","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005, 12: 1209-23. 10.1056\/NEJMoa051688.","journal-title":"N Engl J Med"},{"key":"572_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-244X-8-31","volume":"8","author":"E Johnsen","year":"2008","unstructured":"Johnsen E, Jorgensen HA: Effectiveness of second generation antipsychotics: a systematic review of randomized trials. BMC Psychiatry. 2008, 8: 31-10.1186\/1471-244X-8-31.","journal-title":"BMC Psychiatry"},{"key":"572_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","volume":"161","author":"CU Correll","year":"2004","unstructured":"Correll CU, Leucht S, Kane JM: Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004, 161: 414-425. 10.1176\/appi.ajp.161.3.414.","journal-title":"Am J Psychiatry"},{"key":"572_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1176\/ps.2007.58.4.489","volume":"58","author":"JA Kreyenbuhl","year":"2007","unstructured":"Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC: Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns. Psychiatr Serv. 2007, 58: 489-495. 10.1176\/appi.ps.58.4.489.","journal-title":"Psychiatr Serv"},{"key":"572_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"WA Ray","year":"2009","unstructured":"Ray WA, Chung CP, Murray KT, Hall K, Stein CM: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009, 360: 225-235. 10.1056\/NEJMoa0806994.","journal-title":"N Engl J Med"},{"key":"572_CR36","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2165\/00023210-200115090-00001","volume":"15","author":"J Tauscher","year":"2001","unstructured":"Tauscher J, Kapur S: Choosing the right dose of antipsychotics in schizophrenia: lessons from neuroimaging studies. CNS Drugs. 2001, 15: 671-678. 10.2165\/00023210-200115090-00001.","journal-title":"CNS Drugs"},{"key":"572_CR37","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/01.jcp.0000096247.29231.3a","volume":"23","author":"CA Rijcken","year":"2003","unstructured":"Rijcken CA, Monster TB, Brouwers JR, de Jong-van den Berg LT: Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?. J Clin Psychopharmacol. 2003, 23: 657-659. 10.1097\/01.jcp.0000096247.29231.3a.","journal-title":"J Clin Psychopharmacol"},{"key":"572_CR38","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/appi.ajp.161.7.1301","volume":"161","author":"J Hamann","year":"2004","unstructured":"Hamann J, Langer B, Leucht S, Busch R, Kissling W: Medical decision making in antipsychotic drug choice for schizophrenia. Am J Psychiatry. 2004, 161: 1301-1304. 10.1176\/appi.ajp.161.7.1301.","journal-title":"Am J Psychiatry"},{"key":"572_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1600-0447.2005.00547.x","volume":"112","author":"S Weinmann","year":"2005","unstructured":"Weinmann S, Janssen B, Gaebel W: Guideline adherence in medication management of psychotic disorders: an observational multisite hospital study. Acta Psychiatr Scand. 2005, 112: 18-25. 10.1111\/j.1600-0447.2005.00547.x.","journal-title":"Acta Psychiatr Scand"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-9-24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-9-24\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-9-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,18]],"date-time":"2017-06-18T20:48:46Z","timestamp":1497818926000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-9-24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,16]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["572"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-9-24","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,16]]},"article-number":"24"}}